Front Street Capital Management, Inc. Standard Biotools Inc. Transaction History
Front Street Capital Management, Inc.
- $522 Million
- Q2 2025
A detailed history of Front Street Capital Management, Inc. transactions in Standard Biotools Inc. stock. As of the latest transaction made, Front Street Capital Management, Inc. holds 120,525 shares of LAB stock, worth $156,682. This represents 0.03% of its overall portfolio holdings.
Number of Shares
120,525Holding current value
$156,682% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
166Shares Held
278MCall Options Held
34.9KPut Options Held
0-
Casdin Capital, LLC New York, NY76.1MShares$98.9 Million12.8% of portfolio
-
Viking Global Investors LP58.7MShares$76.2 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$28.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$22.1 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR10.1MShares$13.1 Million0.56% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $102M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...